Skip to main content

Table 2 Uni- and multivariate linear regression analysis of predictors of T50 at one year

From: Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

  Univariate   Multivariate  
Variable β (t-values)* p-value β (t-values)* p-value
Age (years) −0.15 (−0.48) 0.64 0.22 (0.64) 0.53
Gender (% male) 0.079 (0.01) 0.99 −6.30 (− 0.48) 0.63
BMI (kg/m2) 0.84 (0.74) 0.46 0.69 (0.57) 0.57
Smoking 0.65 (0.08) 0.94 −3.12 (−0.25) 0.80
HLA mismatch 1.06 (0.36) 0.72 0.81 (0.25) 0.80
Living donor 15.23 (1.77) 0.08 −2.83 (−0.26) 0.79
Predialytic transplantation 11.13 (1.31) 0.19 11.12 (1.15) 0.25
Pretransplant diabetes −17.65 (−1.68) 0.107 −5.02 (−0.39) 0.70
Treatment −4.12 (−0.51) 0.61 0.37 (0.04) 0.97
T50 baseline (min) 0.36 (4.12) < 0.01 0.37 (3.44) < 0.01
Albumin (g/L) 1.03 (0.64) 0.64 0.15 (0.08) 0.94
ALP (U/L) 0.02 (0.12) 0.90 0.18 (0.95) 0.35
Calcium (mmol/L) 3.48 (0.07) 0.93 −6.11 (−0.12) 0.90
Creatinine (μmol/L) 0.01 (0.06) 0.95 −0.01 (− 0.04) 0.97
Phosphate (mmol/L) −4.79 (−0.30) 0.76 5.07 (0.28) 0.78
PTH (pmol/L) −1.61 (−2.24) 0.09 −1.70 (−2.21) 0.03
  1. Abbreviations: ALP alkaline phosphatase, BMI body mass index, PTH parathyroid hormone, T50; time to 50% transfer to crystalline particles, HLA human leukocyte antigen
  2. Estimates are reported together with their t-values in parenthesis and p-values are in separate columns. *t-value at 95% cutoff 1.96